Susquehanna International Group’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Susquehanna International Group’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-13,400	Closed	-$7K	–	10724
2016 Q3	$7K	Sell	13,400 -1,300	-9%	-$594	﹤0.01%	8298
2016 Q2	$9K	Sell	14,700 -82,000	-85%	-$87.5K	﹤0.01%	8429
2016 Q1	$141K	Sell	96,700 -194,200	-67%	-$383K	﹤0.01%	8253
2015 Q4	$931K	Buy	290,900 +122,800	+73%	+$590K	﹤0.01%	5551
2015 Q3	$1.05M	Sell	168,100 -99,000	-37%	-$925K	﹤0.01%	5640
2015 Q2	$2.65M	Sell	267,100 -89,300	-25%	-$782K	﹤0.01%	4100
2015 Q1	$2.63M	Buy	356,400 +21,500	+6%	+$145K	﹤0.01%	3785
2014 Q4	$1.79M	Buy	334,900 +204,100	+156%	+$1.04M	﹤0.01%	4661
2014 Q3	$658K	Sell	130,800 -345,000	-73%	-$2.12M	﹤0.01%	6711
2014 Q2	$3.19M	Buy	475,800 +22,300	+5%	+$142K	﹤0.01%	3813
2014 Q1	$3.28M	Buy	453,500 +421,500	+1,317%	+$2.5M	﹤0.01%	3496
2013 Q4	$121K	Sell	32,000 -3,400	-10%	-$13.2K	﹤0.01%	8561
2013 Q3	$119K	Buy	35,400 +23,000	+185%	+$80.1K	﹤0.01%	8020
2013 Q2	$41K	Buy	+12,400	New	+$44.9K	﹤0.01%	8020

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

MBT

Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Susquehanna International Group's NWBO Position: Q4 2016 in Review

Susquehanna International Group sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 186,083 shares — an estimated $101K sold.

Susquehanna International Group first reported a position in NWBO in Q4 2013 and held it in 12 quarters. The position peaked at $6.75M in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

Susquehanna International Group reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
Susquehanna International Group sold 186,083 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $101K.
Susquehanna International Group first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2013 and held it in 12 quarters.
Susquehanna International Group's Northwest Biotherapeutics, Inc. Common stock position peaked at $6.75M in Q2 2015.
8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Susquehanna International Group's 13F filing for Q4 2016, filed 14 Feb 2017.